Science to Business: The AI Revolution - Disrupting the Path from Drug Discovery to Patient Care
NovemberNov 07 2018
Science to Business Network Presents...
The AI Revolution: Disrupting the Path From Drug Discovery to Patient Care
- Profile how AI is disrupting business areas from drug discovery to patient diagnosis and treatment
- Discuss the challenges and opportunities in unleashing the power of AI while balancing data integrity, privacy, and a complex regulatory environment
- Explore how Canada can leverage its public and private research infrastructure to become a global leader in AI
With Guest Panelists:
Naheed Khurji (President and CEO, Cyclica)
John Reeves (Partner, Chief Medical Officer, conversationHEALTH)
6:30 pm Panel Discussion + Q&A
Members will receive:
- Discounted entry to any S2BN event across Canada
- Priority registration
- Access to an S2BN members-only networking event
Simon has a Bachelor of Journalism from Ryerson University and a Master of Arts in the History and Philosophy of Science and Technology from the University of Toronto.
Simon has spent 17 years straddling business strategy, marketing and technology in life science-focused startups and agencies. Immediately prior to BenchSci, he led digital marketing initiatives for pharmaceutical and biotechnology companies as SVP, Strategy with Klick Health. He’s passionate about (and a bit obsessed with) scaling innovative solutions to meaningful problems.
Naheed is the President and CEO of Cyclica, a Toronto-based, ventured-backed biotech that is driving drug discovery by empowering scientists in pharma with a cloud-based and AI-augmented platform to enhance how they design, screen, and personalize medicines.
Bruce Seet, PhD, MBA
Bruce Seet is the founder and President of the Science to Business Network, a group dedicated to bridging academia, government and industry. He started his career in bio-pharmaceuticals in 2006 and held multiple roles at GlaxoSmithKline over 8 years. Since 2014, he has been Director, Medical Affairs, at Sanofi Pasteur Canada. He also holds the position of Adjunct Professor at the University of Toronto's Department of Molecular Genetics. Bruce earned a B.Sc (Honours Human Physiology) and a Ph.D. (Microbiology and Immunology) from Western University (London, Canada), followed by a postdoctoral research fellowship at the Lunenfeld Research Institute at Mt. Sinai Hospital (Toronto).
Event is in progress
LocationBrassaii 461 King St W, Toronto
Could not find route!